<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04633525</url>
  </required_header>
  <id_info>
    <org_study_id>2251</org_study_id>
    <nct_id>NCT04633525</nct_id>
  </id_info>
  <brief_title>Defining Optimum Cup Orientation for Hip Replacements Taking Into Account the Individual's Anatomy and Movement Patterns</brief_title>
  <official_title>A Prospective Study to Define Optimum Cup Orientation in Hip Arthroplasty Accounting for the Individual's Anatomy and Movement Patterns</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ottawa Hospital Research Institute</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Ottawa Hospital Research Institute</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to investigate and determine the optimal zone for implanting the&#xD;
      cup component (the ball that sits in the joint socket) in a total hip replacement. Enrolled&#xD;
      participants will have a series of X-rays analyzed before surgery to identify their&#xD;
      individual optimal zone or cup orientation. This information will be provided to the&#xD;
      operating surgeon, who may use this information to influence the placement of the cup&#xD;
      implant. Follow-up X-rays taken after surgery will determine if the cup is within the&#xD;
      suggested optimal zone. Questionnaires will be completed before and after surgery, and data&#xD;
      on complications or issues with the surgery (including incidents of dislocation) will be&#xD;
      collected after surgery.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">November 18, 2020</start_date>
  <completion_date type="Anticipated">January 2024</completion_date>
  <primary_completion_date type="Anticipated">October 2023</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Cup Orientation</measure>
    <time_frame>12 months after surgery</time_frame>
    <description>The degree of cup inclination and anteversion as shown on X-rays</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in Patient Reported Function</measure>
    <time_frame>12 months</time_frame>
    <description>Assess the change in function using the Oxford Hip Score. Total scores range from 0-48. The higher the score, the better the outcome.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Patient Reported Pain</measure>
    <time_frame>12 months</time_frame>
    <description>Assess the change in pain using the Oxford Hip Score. Total scores range from 0-48. The higher the score, the better the outcome.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Patient Reported Health</measure>
    <time_frame>12 months</time_frame>
    <description>Assess the change in general health using the EQ-5D-5L</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Patient Reported Health</measure>
    <time_frame>12 months</time_frame>
    <description>Assess the change in general health using the PROMIS-15</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of Adverse Events</measure>
    <time_frame>Up to 12 months after surgery</time_frame>
    <description>Assess safety and post-operative complications by collecting information on adverse events and serious adverse events</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">400</enrollment>
  <condition>Hip Arthritis</condition>
  <condition>Hip Osteoarthritis</condition>
  <arm_group>
    <arm_group_label>Optimum Cup Orientation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Optimum Cup Orientation</intervention_name>
    <description>Participants will have X-rays taken before surgery to determine the target optimal zone for orientation of the cup implant, using EBRA software. The surgeon may or may not implant in this target zone, depending on what they believe is in the patient's best interest. X-rays will be taken at 12 months after surgery to determine if they target cup orientation was achieved.</description>
    <arm_group_label>Optimum Cup Orientation</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Signed up for primary total hip arthroplasty procedures at the General Campus at The&#xD;
             Ottawa Hospital.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Unwilling or unable to complete study requirements (either X-rays or questionnaires)&#xD;
&#xD;
          -  Unwilling or unable to sign the informed consent form&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>George Grammatopoulos</last_name>
    <role>Principal Investigator</role>
    <affiliation>Ottawa Hospital Research Institute</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Clinical Research Coordinator</last_name>
    <phone>613-737-8899 x 73032</phone>
    <email>meadufresne@ohri.ca</email>
  </overall_contact>
  <location>
    <facility>
      <name>The Ottawa Hospital</name>
      <address>
        <city>Ottawa</city>
        <state>Ontario</state>
        <zip>K1H 8L6</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Meaghan Dufresne</last_name>
      <email>meadufresne@ohri.ca</email>
    </contact>
    <investigator>
      <last_name>George Grammatopoulos</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>February 2021</verification_date>
  <study_first_submitted>August 11, 2020</study_first_submitted>
  <study_first_submitted_qc>November 12, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">November 18, 2020</study_first_posted>
  <last_update_submitted>February 22, 2021</last_update_submitted>
  <last_update_submitted_qc>February 22, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">February 24, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Hip Replacement</keyword>
  <keyword>Hip Arthroplasty</keyword>
  <keyword>Arthritis</keyword>
  <keyword>Osteoarthritis</keyword>
  <keyword>Hip dislocation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Arthritis</mesh_term>
    <mesh_term>Osteoarthritis</mesh_term>
    <mesh_term>Osteoarthritis, Hip</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

